SonoThera

SonoThera's mission is to develop gene therapies that address the root causes of human diseases. SonoThera is expanding the possibilities of treating diseases with ultrasound-guided, non-viral gene therapy, focusing on conditions with suboptimal or nonexistent treatments. The company is also developing an ultrasound-guided, non-viral gene therapy platform and treatment approach aimed at delivering next-generation safe and effective gene medicines to patients. This platform leverages sonoporation, a microbubble-mediated biophysical process, to non-invasively deliver genetic payloads and selectively target various organs within the body. Its goal is to improve the lives and health of millions of people.